R&D | April 20, 2026
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
The programme is being implemented in collaboration with Grow Well Foundation and is expected to expand in a phased manner
The company allocated €56 million to research and development for next-generation line solutions
The investment case for health technology in India is frequently overstated in one direction and understated in another
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
Muted movement reflects consolidation phase as investors await earnings triggers
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
Subscribe To Our Newsletter & Stay Updated
